Finance

Lists
Why is 1548 up 5,38%?
Dive Deeper
1548:HKG
Genscript Biotech Corp
HK$33,30
+5,38%
(+1,70) 1D
16 Okt., 16:08:14 GMT+8  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1548...
Open
HK$33,30
High
HK$34,34
Low
HK$32,16
Mkt. cap
76,05 mjd
Avg. vol.
38,11 m
Volume
53,41 m
52-wk high
HK$49,46
52-wk low
HK$10,36
EPS
-HK$2,29
Shares outstanding
1,83 mjd
No. of employees
6 k
Open
HK$33,30
High
HK$34,34
Low
HK$32,16
Mkt. cap
76,05 mjd
Avg. vol.
38,11 m
Volume
53,41 m
52-wk high
HK$49,46
52-wk low
HK$10,36
EPS
-HK$2,29
Shares outstanding
1,83 mjd
No. of employees
6 k
News stories
From web sources and news partners
About Genscript Biotech Corp
CEO-
Employees6,14 k
Founded2002
HeadquartersPiscataway, New Jersey, Verenigde State van Amerika
SectorHealth care
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
220,38 m
220,38 m
202,11 m
202,11 m
Cost of goods sold
104,09 m
104,09 m
98,75 m
98,75 m
Cost of revenue
104,09 m
104,09 m
98,75 m
98,75 m
Research and development expenses
19,96 m
19,96 m
19,72 m
19,72 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
58,71 m
58,71 m
58,55 m
58,55 m
Operating expense
78,21 m
78,21 m
78,58 m
78,58 m
Total operating expenses
182,30 m
182,30 m
177,33 m
177,33 m
Operating income
38,08 m
38,08 m
24,78 m
24,78 m
Other non operating income
946,50 k
946,50 k
2,45 m
2,45 m
EBT including unusual items
-235,21 m
-235,21 m
-59,71 m
-59,71 m
EBT excluding unusual items
-27,78 m
-27,78 m
-60,33 m
-60,33 m
Income tax expense
18,72 m
18,72 m
4,96 m
4,96 m
Effective tax rate
-7,96%
-7,96%
-8,31%
-8,31%
Other operating expenses
-
-
-
-
Net income
-253,68 m
-253,68 m
-64,67 m
-64,67 m
Net profit margin
-115,11%
-115,11%
-32,00%
-32,00%
Earnings per share
-
-
-
-
Interest and investment income
8,09 m
8,09 m
3,96 m
3,96 m
Interest expense
-4,05 m
-4,05 m
-3,20 m
-3,20 m
Net interest expenses
4,05 m
4,05 m
765,50 k
765,50 k
Depreciation and amortization charges
-
-
-
-
EBITDA
54,34 m
54,34 m
41,98 m
41,98 m
Gain or loss from assets sale
423,50 k
423,50 k
430,00 k
430,00 k
AI content may include mistakes. Learn more
Google-programme